News
ADXN
24.75
-3.21%
-0.82
Weekly Report: what happened at ADXN last week (0408-0412)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
IN8bio stock increased by 47.7% to $1.61 during Wednesday's pre-market session. Jaguar Health (NASDAQ:JAGX) shares rose 25.0% during the session. China SXT Pharmaceuticals shares moved upwards by 24.85%. Losers in the market were BioSig Technologies and Kineta.
Benzinga · 6d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.0% to $10.16 during Tuesday's regular session. BioSig Technologies stock increased by 27.41% and Tilray Brands stock decreased by 19.5%. The company's Q4 earnings report came out yesterday.
Benzinga · 6d ago
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers. S&P 500 Health Care Sector +0.11% to 1666.38. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 6d ago
MYMD, MDIA and LIFW are among premarket gainers
On the Move MYMD, MDIA and LIFW are among premarket gainers. Acrivon Therapeutics (ACRV) announces $130 million private placement. Laser Photonics (LASE) secures order from L3Harris for a new laser.
Seeking Alpha · 04/09 12:48
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.3% to $10.19 during Tuesday's pre-market session. MyMD Pharmaceuticals stock rose 33.85% and Addex Therapeutic stock rose 24.48% during the same session. Other gainers included Vincerx Pharma, Neogen and Tilray Brands.
Benzinga · 04/09 12:09
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out on Tuesday morning. Biophytis stock is rocketing close to 50% after announcing its 2023 results. Moving stocks this morning are earnings reports, clinical trial data and more. Biggest Pre-Market Stock Movers include 10 top gainers and 10 top losers.
Investorplace · 04/09 11:27
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Biophytis S.A. Posted a FY23 loss of €0.03 per share. MyMD Pharmaceuticals, Inc. Shares rose 40% in pre-market trading after jumping 22% on Monday. Biophytis shares jumped 55.2% to $0.4920 in today's pre- market trading.
Benzinga · 04/09 10:05
Weekly Report: what happened at ADXN last week (0401-0405)?
Weekly Report · 04/08 09:44
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
STAAR Surgical shares jumped 13.3% to $44.30 on Thursday. The company issued strong preliminary first-quarter net sales guidance. TC Biopharm (Holdings) Plc shares climbed 130.1% in the mid-day session.
Benzinga · 04/04 17:21
EIGR, ADXN and BROG are among premarket gainers
On the Move EIGR, ADXN and BROG are among premarket gainers. Tevogen (TVGN) +95%. HWH International (HWH) +57%. Levi Strauss (LEVI) +14%. Candel Therapeutics (CADL) soars on positive data from mid-stage pancreatic cancer drug trial.
Seeking Alpha · 04/04 13:20
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tevogen Bio Holdings stock rose 85.5% to $4.86 during Thursday's pre-market session. Candel Therapeutics (NASDAQ:CADL) shares rose 27.97% and Healthcare Triangle stock rose 23.56% in the same session. Losers Telesis Bio (NASdaq:TBIO) stock fell 11.8% during the session. Q4 earnings came out today.
Benzinga · 04/04 12:09
Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Flora Growth Corp. Fell sharply in today's pre-market trading. The company reported the launch of a proposed public offering of common shares. Levi Strauss & Co. Shares rose 7.9% on Wednesday after the company reported upbeat earnings for its first quarter. HWH International Inc. And VivoPower surged 175% and 14.5% in pre- market trading.
Benzinga · 04/04 11:58
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. The company reportedly issued a weak outlook at the J.P. Morgan Retail Roundup investor conference. ARCA biopharma, Inc. Shares climbed 108% in the mid-day session.
Benzinga · 04/03 17:56
FibroGen, Acorda Therapeutics, Enveric Biosciences among healthcare movers
Healthcare On the Move: FibroGen, Acorda Therapeutics, Enveric Biosciences among healthcare movers. S&P 500 Health Care Sector +0.26% to 1685.56. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 04/03 14:00
Addex stock climbs on launch of new company, Neurosterix
Addex stock climbs on launch of new company, Neurosterix. The company is focused on developing allosteric modulators for the treatment of underserved neurological disorders. Addex Therapeutics shares rose about 14% premarket after it announced the launch of the new company.
Seeking Alpha · 04/03 13:03
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday morning. LAMF Global Ventures stock is rocketing 122% after getting shareholder approval for a business combination. View stock is plummeting more than 63% after announcing Chapter 11 filings. Earnings reports, business combinations, bankruptcy filings and more are the biggest news worth reading.
Investorplace · 04/03 11:30
Addex And Perceptive Launch Neurosterix With $63M For Neurological Disorders
Benzinga · 04/03 07:31
Addex Announces Launch Of Neurosterix In Partnership With Perceptive - Quick Facts
NASDAQ · 04/03 05:31
More
Webull provides a variety of real-time ADXN stock news. You can receive the latest news about Addex Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About ADXN
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.